pityriacitrin

the yeast Malassezia furfur; structure in first source

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

1.	Chen, Yan-Xiu: 1 article (11/2017)
2.	Lan, Wen-Jian: 1 article (11/2017)
3.	Li, Hou-Jin: 1 article (11/2017)
4.	Ma, Wen-Zhe: 1 article (11/2017)
5.	Tian, Guo-Bao: 1 article (11/2017)
6.	Xu, Jun: 1 article (11/2017)
7.	Xu, Meng-Yang: 1 article (11/2017)
8.	Yang, De-Po: 1 article (11/2017)
9.	Zeng, Kun-Jiao: 1 article (11/2017)
10.	Alaoui-Jamali, Moulay: 1 article (12/2011)

1.	Prostatic Neoplasms (Prostate Cancer) 12/01/2011 - "Biological studies revealed that pityriacitrin has a weak antiproliferative activity against a panel of breast and prostate cancer cell lines, whereas some of its derivatives exhibited stronger and potent activity, which was associated with induction of both cell apoptosis and necrosis."
2.	Necrosis 12/01/2011 - "Biological studies revealed that pityriacitrin has a weak antiproliferative activity against a panel of breast and prostate cancer cell lines, whereas some of its derivatives exhibited stronger and potent activity, which was associated with induction of both cell apoptosis and necrosis."
3.	Hypopigmentation (Hypomelanosis) 12/01/2007 - "Pityriacitrin (PIT), produced by Malassezia yeasts, is an UV absorbing substance that might cause hypopigmentation in pityriasis versicolor alba. "
4.	Tinea Versicolor (Pityriasis Versicolor) 12/01/2007 - "Pityriacitrin (PIT), produced by Malassezia yeasts, is an UV absorbing substance that might cause hypopigmentation in pityriasis versicolor alba. "
5.	Rhabdomyosarcoma 11/01/2017 - "Dichotomocej A (1) displayed moderate cytotoxicity against the human rhabdomyosarcoma cell line RD with an IC50 value of 39.1 µM, and pityriacitrin (22) showed moderate cytotoxicity against the human colon carcinoma cell line HCT116 with an IC50 value of 35.1 µM."